These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Suzuki T, Otsuka A, Ozono S. Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297 [Abstract] [Full Text] [Related]
3. Effects of Withdrawing α1-Blocker from Combination Therapy with α1-Blocker and 5α-Reductase Inhibitor in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective and Comparative Trial Using Urodynamics. Matsukawa Y, Takai S, Funahashi Y, Majima T, Kato M, Yamamoto T, Gotoh M. J Urol; 2017 Oct; 198(4):905-912. PubMed ID: 28499730 [Abstract] [Full Text] [Related]
4. Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin. Ito H, Sano F, Ogawa T, Yao M. Int J Urol; 2014 Jan; 21(1):108-12. PubMed ID: 23662900 [Abstract] [Full Text] [Related]
6. Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study). Matsukawa Y, Funahashi Y, Takai S, Majima T, Ogawa T, Narita H, Kato M, Gotoh M. J Urol; 2017 Feb; 197(2):452-458. PubMed ID: 27615436 [Abstract] [Full Text] [Related]
7. Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness--new standards for noninvasive bladder outlet obstruction diagnosis? Franco G, De Nunzio C, Leonardo C, Tubaro A, Ciccariello M, De Dominicis C, Miano L, Laurenti C. J Urol; 2010 Jun; 183(6):2270-4. PubMed ID: 20400138 [Abstract] [Full Text] [Related]
9. Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal? Yamanishi T, Kaga K, Fuse M, Shibata C, Kamai T, Uchiyama T. Int J Urol; 2015 Dec; 22(12):1143-8. PubMed ID: 26310102 [Abstract] [Full Text] [Related]
10. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride. Wada N, Matsumoto S, Kita M, Hashizume K, Kakizaki H. Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474 [Abstract] [Full Text] [Related]
11. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study. Matsukawa Y, Gotoh M, Komatsu T, Funahashi Y, Sassa N, Hattori R. J Urol; 2013 Jan; 189(1 Suppl):S117-21. PubMed ID: 23234615 [Abstract] [Full Text] [Related]
12. Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study. Fusco F, Creta M, Longo N, Persico F, Franco M, Mirone V. BMC Urol; 2018 Mar 05; 18(1):12. PubMed ID: 29502524 [Abstract] [Full Text] [Related]
14. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms]. Park SC, Lee JW, Rim JS. Actas Urol Esp; 2012 Mar 05; 36(3):165-70. PubMed ID: 22018947 [Abstract] [Full Text] [Related]
15. Which is a better indicator of bladder outlet obstruction in patients with benign prostatic enlargement--intravesical protrusion of prostate or bladder wall thickness? Aganovic D, Hasanbegovic M, Prcic A, Kulovac B, Hadziosmanovic O. Med Arch; 2012 Mar 05; 66(5):324-8. PubMed ID: 23097971 [Abstract] [Full Text] [Related]
16. Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study. Mariappan P, Brown DJ, McNeill AS. J Urol; 2007 Aug 05; 178(2):573-7; discussion 577. PubMed ID: 17570437 [Abstract] [Full Text] [Related]
17. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study. Matsukawa Y, Gotoh M, Komatsu T, Funahashi Y, Sassa N, Hattori R. J Urol; 2009 Dec 05; 182(6):2831-5. PubMed ID: 19837428 [Abstract] [Full Text] [Related]
18. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study. Matsukawa Y, Majima T, Matsuo K, Funahashi Y, Kato M, Yamamoto T, Gotoh M. Int J Urol; 2018 Mar 05; 25(3):246-250. PubMed ID: 29164680 [Abstract] [Full Text] [Related]
19. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms. Steele GS, Sullivan MP, Sleep DJ, Yalla SV. J Urol; 2000 Aug 05; 164(2):344-8. PubMed ID: 10893581 [Abstract] [Full Text] [Related]
20. Effects of dutasteride on storage and voiding symptoms in male patients with lower urinary tract symptoms as a result of benign prostatic obstruction: the 1-year outcomes from a prospective urodynamic study. Matsukawa Y, Gotoh M, Kato M, Funahashi Y, Narita M, Mitsui K. Int J Urol; 2014 Aug 05; 21(8):826-30. PubMed ID: 24661225 [Abstract] [Full Text] [Related] Page: [Next] [New Search]